E-health
Supporting the development of digital health that will drive the medicine of tomorrow is at the heart of IHU ICAN’s strategy.
The IHU ICAN strives to support manufacturers of innovative e-health solutions, helping them to meet the new clinical requirements introduced by European regulations 2017/745 for medical devices and 2017/746 for diagnostic medical devices. in vitro.
ICAN supports e-health companies in the development of new innovative devices based on a diversified service and collaboration offer:
- Consulting and targeted expertise on preclinical and clinical strategy in the field of cardiometabolism and nutrition pathologies (NASH, heart failure, diabetes and chronic wounds, rare diseases, etc.).
- Identification of patient needs
- Advice on the identification of patient needs, definition of the expected performance and the target population of the medical device
- Scientific and medical support for the design of the clinical evaluation or performance evaluation plan
- Scientific and medical support for the drafting of clinical study protocols
Conducting clinical studies with a dedicated and expert investigation platform on cardiometabolic diseases and nutrition
